Egawa et al(1) presented a comprehensive review of nearly 1401 patients who were administered immunotherapy for various solid cancers including cancer of ovary, lung cancer, stomach cancer, liver cancer . It has proven that the cell based immunotherapy when combined with conventional treatment the efficacy improves by 20-30%. It was found that the less than 1% patients experiencing fever or a rash and this treatment is largely free of side effects when compared with other standard cancer therapies.